A European network to develop virtual twin technology for personalized stroke management in atrial fibrillation: the TARGET consortium

Atrial fibrillation (AF) is a prevalent heart arrhythmia that increases stroke risk, leading to severe complications, high costs, and poor recovery outcomes. To address this, the European Union’s Horizon Europe research programme has funded the TARGET project to develop personalized stroke management strategies for AF-related stroke (AFRS) patients. To achieve this, TARGET will capitalize on the power of artificial intelligence (AI), virtual twin technologies, and in silico trials and will further advance the work in the direction of the personalization of care.